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Fasting glucose is associated with future risk of type 2 diabetes and ischemic heart disease and is tightly regulated despite
considerable variation in quantity, type, and timing of food intake. In pregnancy, maternal fasting glucose concentration
is an important determinant of offspring birth weight. The key determinant of fasting glucose is the enzyme glucokinase
(GCK). Rare mutations of GCK cause fasting hyperglycemia and alter birth weight. The extent to which commonvariation
of GCK explains normal variation of fasting glucose and birth weight is not known. We aimed to comprehensively deﬁne
the role of variation of GCK in determination of fasting glucose and birth weight, using a tagging SNP (tSNP) approach
and studying 19,806 subjects from six population-based studies. Using 22 tSNPs, we showed that the variant rs1799884
is associated with fasting glucose at all ages in the normal population and exceeded genomewide levels of signiﬁcance
( ). rs3757840 was also highly signiﬁcantly associated with fasting glucose ( ), but haplotype analysis59 57Pp 10 Pp 8# 10
revealed that this is explained by linkage disequilibrium ( ) with rs1799884. A maternal A allele at rs1799884was2r p 0.2
associated with a 32-g (95% conﬁdence interval 11–53 g) increase in offspring birth weight ( ). Genetic variationPp .002
inﬂuencing birth weight may have conferred a selective advantage in human populations. We performed extensive
population-genetics analyses to look for evidence of recent positive natural selection on patterns ofGCK variation.However,
we found no strong signature of positive selection. In conclusion, a comprehensive analysis of common variation of the
glucokinase gene shows that this is the ﬁrst gene to be reproducibly associated with fasting glucose and fetal growth.
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Blood glucose concentration is tightly regulated inhumans,
despite considerable variation in quantity, type, and tim-
ing of food intake. The appropriate release of insulin and
other hormones prevents the damaging effects caused by
hyper- or hypoglycemia. In the absence of food, blood
glucose levels return to a tightly deﬁned level of 3.5–5.5
mmol/liter in young adults.
Variation of fasting glucose levels is clinically important.
Even in the normal range, the fasting glucose level is as-
sociated with future risk of type 2 diabetes and ischemic
heart disease.1–3 During pregnancy, maternal fasting glu-
cose concentration is an important determinant of off-
spring birth weight.4,5 Maternal hyperglycemia stimulates
the release of fetal insulin, an important fetal growth fac-
tor. Factors such as age and obesity explain some of the
variation in fasting glucose levels within a population,
but, when these are accounted for, considerable variation
between individuals still remains. Fasting glucose level is
strongly heritable, and much of the interindividual differ-
ences in fasting glucose concentration can be explained
by genetic variation.6–8
One of the principal regulators of fasting glucose
concentrations is the enzyme glucokinase (GCK [MIM
138079]).9 GCK is predominantly expressed in the pan-
creas and liver and catalyzes the ﬁrst rate-limiting reaction
in glycolysis.9 Its lack of inhibition by its product and its
sensitivity to changes in glucose concentrations within
the physiological range make it ideally suited for its role
as the pancreatic b-cell glucose sensor.9
The key role of GCK in glucose homeostasis is demon-
strated by the impact of rare gene mutations that cause
a subtype of diabetes known as “maturity-onset diabetes
of the young” (MODY [MIM 606391]).10–12 GCK MODY is
characterized by mild, stable hyperglycemia during fast-
ing.13 GCKMODYmutations also affect birthweight. Chil-
dren born to mothers with a GCK mutation are ∼600 g
heavier at birth14; conversely, children who have a GCK
MODY mutation but whose mothers do not are ∼500 g
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Table 1. Initial tSNP Association Results for Fasting Glucose in the EFS
SNP
Alleles
(1/2)
Mean (SD) Glucose Level [No. of Subjects] for Genotype
ANOVA P11 12 22
rs3217943 C/T 4.48 (.47) [84] 4.53 (.44) [602] 4.53 (.43) [783] .594
rs2537184 G/A 4.53 (.44) [372] 4.53 (.44) [744] 4.51 (.44) [377] .985
rs882020 T/C 4.68 (.36) [16] 4.53 (.46) [324] 4.53 (.43) [1,117] .371
rs2268575 C/T 4.67 (.44) [37] 4.52 (.45) [438] 4.52 (.43) [976] .120
rs2971679 T/C 4.53 (.47) [42] 4.53 (.45) [403] 4.53 (.44) [1,039] .995
rs2971677 A/C 4.51 (.45) [39] 4.52 (.45) [398] 4.53 (.43) [1,020] .870
rs2971676 A/G 4.46 (.36) [17] 4.52 (.45) [232] 4.53 (.44) [1,240] .765
rs4724290 T/C 4.49 (.43) [108] 4.53 (.44) [590] 4.53 (.44) [735] .714
rs2041547 C/T 4.55 (.43) [390] 4.53 (.45) [744] 4.49 (.41) [355] .212
rs2971671 C/T 4.60 (.46) [68] 4.56 (.44) [477] 4.51 (.43) [887] .054
rs2284777 C/T 4.52 (.34) [19] 4.52 (.43) [336] 4.53 (.43) [1,144] .890
rs758988 C/A 4.52 (.44) [1,028] 4.54 (.45) [421] 4.51 (.37) [44] .727
rs2284770 A/T 4.50 (.45) [460] 4.54 (.44) [673] 4.52 (.41) [320] .345
rs2284769 G/C 4.67 (.29) [19] 4.51 (.45) [291] 4.53 (.44) [1,190] .234
rs1799884 T/C 4.53 (.51) [55] 4.58 (.44) [449] 4.50 (.43) [988] .010
rs1476891 A/G 4.53 (.44) [683] 4.52 (.45) [614] 4.55 (.45) [158] .775
rs3757840 G/T 4.48 (.42) [350] 4.53 (.43) [714] 4.57 (.48) [407] .016
rs34976798a G/T 4.68 (.28) [6] 4.49 (.44) [173] 4.53 (.44) [1,270] .347
rs2908287 G/A 4.52 (.43) [842] 4.52 (.44) [546] 4.58 (.46) [100] .408
rs2331003 A/G 4.53 (.42) [940\ 4.53 (.44) [490] 4.56 (.42) [67] .847
rs1003573 C/T 4.53 (.43) [549] 4.52 (.43) [656] 4.54 (.46) [233] .919
rs917791 G/A 4.55 (.46) [193] 4.51 (.43) [698] 4.54 (.40) [551] .311
NOTE.—Glucose is measured in mmol/liter.
a with rs13239289.2r p 1
Table 2. Characteristics of Subjects Examined in the Fasting Glucose Study
Characteristica
Finding for
EFS PEB Adults BCG InChianti BWHHS
ALSPAC
Children
No. (% male) 1,552 (50) 356 (52) 626 (53) 1,022 (43) 2,652 (0) 839 (54)
Median age, in years (IQR) 32.0 (7.0) 34.1 (7.0) 25.0 (1.0) 71.0 (12.0) 68.0 (9.0) 8.0 (.0)
Median BMI, in kg/m2 (IQR) 24.8 (5.6) 25.9 (5.4) 24.3 (7.3) 27.0 (5.5) 27.6 (5.0) 16.5 (4.0)
Median fasting glucose, in mmol/liter (IQR) 4.5 (.6) 4.7 (.6) 4.6 (.6) 4.8 (.7) 5.6 (.8) 4.9 (.7)
Median fasting blood insulin, in pmol/liter (IQR) 55.3 (38.5) 56.7 (36.8) 39.6 (25.8) 66.4 (48.3) Not applicable 37.7 (44.6)
NOTE.—Only results of successfully genotyped subjects are included.
a IQR p interquartile range.
lighter at birth.14 If both the mother and the child have
a GCK mutation, the effects cancel each other out and the
baby is of normal birth weight.14
In the past, low–birth-weight babies had a high level of
neonatal mortality, which was more marked before mod-
ern medical support was available. In contrast, high birth
weight can pose a danger to the mother and to the child
during birth. Although it is likely that natural selection
has had a strong inﬂuence on birth-weight variation, sev-
eral different models of selection are plausible. For ex-
ample, it may be that variation inﬂuencing birth weight
evolves under purifying selection, which eliminates alleles
that increase or decrease birth weight beyond the optimal
value for a given environment. Alternatively, if the pop-
ulation-average birth weight is not close to the optimal
value, new variants that improve birth weight will be ad-
vantageous. Hence, variants that affect birth weight are in-
teresting candidates for population-genetics studies aimed
at understanding the evolution of birth weight.
The extent to which common variation ofGCK explains
normal variation of fasting glucose and birth weight is not
known. We recently described an association between a
variant of the GCK promoter, GCK-30 (rs1799884 [dbSNP]),
and fasting glucose in young adults and pregnant wo-
men.15 We also demonstrated an association of the minor
allele with increased offspring birth weight.15 It is not
known whether further variation in the GCK gene alters
fasting glucose or birth weight or the extent to which
natural selection inﬂuenced variation of this gene. In the
present study, we aimed to comprehensively deﬁne the
role of variation ofGCK on fasting glucose andbirthweight,
using a tagging SNP (tSNP) approach and studying 19,806
subjects from six different studies.
Material and Methods
Association Study
Determining the Linkage-Disequilibrium (LD) Structure of the GCK
Gene Region.—To determine the LD structure of GCK (45 kb) and
the surrounding region (5 kb upstream and 19 kb downstream
of GCK isoform 1), we ﬁrst sequenced the exons of 43 unrelated
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Figure 1. LD structure of glucokinase. r2 values between the 84 SNPs across a 116-kb region are presented. Arrows indicate tSNPs
used in association study.
U.K. white subjects. No common (15% minor-allele frequency)
coding variants were identiﬁed. We then used a directed rese-
quencing approach, centering our PCR amplicons on SNPs re-
ported in the November 2002 version of the Santa Cruz genome
Web site. We initially focused on common SNPs in regions of
conservation among humans, mice, and rats (using mVista), and
we deﬁned a cut-off of 1100 bp that showed 175%matches. Next,
to increase the average SNP density to 1 SNP per 2 kb, we chose
additional amplicons randomly. This study was initiated before
the availability of HapMap data.
Choice of tSNPs.—Weused the Tagger program to choose tSNPs.16
We forced in rs1799884, because of the previous association evi-
dence, and rs34976798, which was discovered in our population-
genetics survey (see table 1). The latter was chosen because it tags
a high-frequency–derived haplotype in the non-African samples.
A pairwise tSNP approach was equally efﬁcient as a multimarker
approach, so only single-marker tSNPs were used.
Fasting glucose initial study: 1,552 subjects from the Exeter Family
Study (EFS).—We genotyped 1,552 subjects (median age 33 years)
from the population-based EFS, to test for nominal associations
( ) of tSNPs. The EFS has been described in detail else-P ! .05
where.17,18 The clinical characteristics of these and the replication
studies’ subjects are presented in table 2. Subjects from all studies
with fasting glucose over the normal range (16 mmol/liter) were
excluded. Brieﬂy, the EFS is a study of newborn babies and their
parents from a geographically deﬁned region of Exeter, United
Kingdom.17,18 Fasting glucose was measured using dry-slide tech-
nology on Vitros 950 analyzers (Ortho Clinical) before December
2001 and with manufacturer’s standard reagents on Modular an-
alyzers (Roche Diagnostics) thereafter.
Fasting glucose replication studies.—We used ﬁve population-based
studies for replication of nominally signiﬁcant tSNPs. We studied
356 parents (median age 35 years) from the Plymouth EarlyBird
study (PEB).19 The PEB is a nonintervention prospective study of
school-aged children and their parents. Fasting glucose was mea-
sured on a Cobas Integra 700 analyzer (Roche Diagnostics).
We studied 626 subjects (median age 25 years) from the Barry
Caerphilly Growth study (BCG).20 These subjects are from the
follow-up of consecutively born infants, from the towns of Barry
and Caerphilly in South Wales, born between 1972 and 1974.
Between 1997 and 1999, all the original children who had com-
pleted the 5-year follow-up were traced, and they completed a
questionnaire and attended a screening clinic, where growth and
oral glucose tolerance test measurements were taken.
We studied 1,022 subjects (median age 71 years) from the In-
vecchiare in Chianti study (InChianti), a prospective population-
based cohort of elderly Italians from two towns (Greve in Chianti
and Bagno a Ripoli) from the Chianti region of Tuscany. The study
includes randomly selected participants aged 65–102 years and
30 men and women from each age decade between 20 and 70
years. The data collection started in September 1998 and was com-
pleted in March 2000. Fasting glucose concentration was deter-
mined by an enzymatic colorimetric assay, with use of a modiﬁed
glucose-oxidase-peroxidase method and a Roche-Hitachi 917 an-
alyzer (Roche Diagnostics).
We studied 2,652 subjects (median age 68 years) from the Brit-
ish Women’s Health and Heart Study (BWHHS). The BWHHS is
a cohort of women aged 60–79 years, randomly selected from 23
British towns.21 Baseline data were collected between April 1999
and March 2001.
We studied 839 children (median age 8 years) from the Avon
Longitudinal Study of Parents and Children (ALSPAC) (the only
subjects from the ALSPAC study for whom fasting glucose mea-
surements were available). Glucose was measured by the glucose-
oxidase method on a YSI 2300 stat plus analyzer. Further details
of the study are described in the “Birth-weight study” section.
Blood samples were taken after a minimum 6-h fast. Plasma glu-
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Figure 2. Comparison of LD structure determined in this study
with that determined from HapMap 2 data. The LD structures are
based on the r2 values between the 17 SNPs that are present in
both data sets.
Figure 3. Comparison of LD structure determined for 16 Italians
from the Natural Selection study with that determined from U.K.
samples used for the tSNP-association study. The LD structure is
based on the r2 and values between 20 SNPs that are present in
both data sets.
cose was measured by a glucose oxidase Trinder method,22 with
use of a Hitachi Modular analyzer.
Birth-weight study.—We examined ALSPAC subjects for the as-
sociation of maternal and offspring GCK polymorphisms with
offspring birth weight. ALSPAC is a prospective study of preg-
nancies recruited from all pregnant women in three Bristol-based
District Health Authorities with expected delivery dates between
April 1991 and December 1992. We have reported elsewhere the
association of one GCK polymorphism with offspring birth weight
in 1,159 of the ALSPACmother-child pairs.15 In the present study,
we extended this earlier analysis by including 16,500 mother-
child pairs. Birth weights were taken from hospital records, and
gestational age was estimated from the last menstrual period and
ultrasound data. For the present study, subjects born after ges-
tation of !36 wk, nonwhites, and twins were excluded from the
analysis.
Association-study statistics.—All standard statistical analyses were
performed using Stata SE version 9 (StataCorp). We used analysis
of variance (ANOVA) and linear regression to test for association
of fasting glucose and birth weight with genotype. For LD statis-
tics and tSNP identiﬁcation, we used Tagger.16 For the haplotype
analyses, we used qtphase from the unphased suite of programs.23
Fixed-effects meta-analysis statistics and plots were generated us-
ing Stats Direct version 2.4.2 (Sale), with a weighted-mean-dif-
ference approach. For the association of genotype with fasting
glucose, we included only normal, glucose-tolerant subjects in
our analyses and therefore excluded anyonewith a fasting glucose
16 mmol/liter. For the studies of elderly subjects, this meant ex-
clusion of a high proportion of subjects (13.9% from InChianti
and 36.5% from the BWHHS). We therefore also performed the
analyses excluding only World Health Organization–deﬁned dia-
betic subjects (fasting glucose 17 mmol/liter). For the birth-weight
studies, we analyzed (1) the effect of maternal genotype on birth
weight both with and without correction for fetal genotype and
(2) the effect of fetal genotype on birth weight both with and
without correction for maternal genotype.
Power.—We usedQuanto for power calculations.24 For the initial
study of all tSNPs, with the assumption of an additive model and
an allele frequency of 20%, we had ∼80% power to detect a per-
allele effect on fasting glucose of 10.055 mmol/liter, at .P ! .05
We did not correct for the testing of multiple SNPs; instead, we
included all nominally signiﬁcant SNPs ( ) in the replicationP ! .05
studies. For birth weight, with the assumption of an additive
model and an allele frequency of 20%, the ALSPAC cohort pro-
vided ∼80% power to detect per-allele differences of 126 g for
both maternal and fetal genotype analyses at the level ofP ! .05
signiﬁcance.
Genotyping method.—All genotyping was performed by Kbio-
science. Details of the company and the KASPar genotyping
method can be found at the Kbioscience Web site.
Genotyping quality control.—In the initial study of the EFS sub-
jects, we analyzed 23 tSNPs, and all were in Hardy-Weinberg equi-
librium (HWE) ( ) except rs2537185 ( ). The9P 1 .01 Pp 4# 10
overall success rate for the 23 tSNPs in the initial studywas 94.6%;
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Table 3. Fasting Glucose Results for rs1799884 and rs3757840 for All Cohorts in the Present Study
Study
Mean (SD) Glucose Level [No. of Subjects] for
rs1799884 rs3757840
GG GA AA
Dominant
P CC CA AA
Linear Trend
P
ALSPAC Children 4.90 (.32) [506] 4.98 (.32) [207] 4.95 (.35) [21] .008 4.87 (.32) [174] 4.94 (.32) [368] 4.95 (.32) [180] .02
BCG 4.57 (.38) [426] 4.64 (.37) [180] 4.48 (.45) [18] .13 4.57 (.41) [127] 4.59 (.36) [324] 4.64 (.40) [166] .10
EFS 4.50 (.43) [988] 4.58 (.44) [449] 4.53 (.51) [55] .01 4.48 (.42) [350] 4.53 (.43) [714] 4.57 (.48) [407] .02
PEB 4.65 (.69) [224] 4.75 (.41) [94] 4.66 (.48) [14] .08 4.61 (.44) [81] 4.69 (.45) [172] 4.79 (.48) [76] .01
BWHHS 5.49 (.39) [1,671] 5.54 (.37) [678] 5.60 (.28) [69] .001 5.48 (.41) [594] 5.51 (.38) [1,238] 5.53 (.35) [578] .03
InChianti 4.77 (.49) [657] 4.82 (.51) [321] 4.95 (.47) [44] .03 4.76 (.51) [178] 4.79 (.49) [456] 4.80 (.50) [293] .40
NOTE.—Glucose is measured in mmol/liter. The data are presented in ascending order of the median age of the cohort. We chose to present the data this way because
of the relatively few AA genotypes for rs1799884 and because our previous data15 and the initial cohort suggested a dominant model. However, given the high frequency
of the rs3757840 minor allele and the data from the EFS, an additive model appeared to ﬁt best for this SNP.
Table 4. Haplotype Results for the Association of Fasting Glucose against rs1799884 and rs3757840 for All Cohorts
Study
Mean (SD) Glucose Level [No. of Subjects] for Haplotype Difference in Glucose (95% CI) [P] for Pairwise Haplotype Comparisona
GC GA AA
Global
P GA and GC AA and GA AA and GC
ALSPAC Children 4.91 (.01) [707] 4.92 (.01) [455] 4.99 (.02) [241] .009 .014 (.02, .05) [.46] .063 (.01, .11) [.013] .077 (.03, .12) [.001]
BCG 4.58 (.02) [571] 4.62 (.02) [439] 4.61 (.03) [208] .21 .041 (.01, .09) [.08] .01 (.07, .05) [.70] .03 (.03, .09) [.31]
EFS 4.50 (.01) [1,293] 4.55 (.01) [886] 4.58 (.02) [511] .002 .04 (.00, .08) [.03] .08 (.03, .12) [.0008] .04 (.01, .08) [.15]
PEB 4.67 (.03) [277] 4.72 (.04) [178] 4.78 (.05) [103] .09 .055 (.03, .14) [.21] .06 (.05, .02) [.31] .11 (.06, .16) [.03]
BWHHS 5.50 (.01) [2,301] 5.51 (.01) [1,487] 5.55 (.01) [786] .008 .01 (.02, .04) [.64] .05 (.01, .08) [.005] .05 (.02, .08) [.0007]
InChianti 4.79 (.02) [817] 4.78 (.02) [666] 4.86 (.03) [384] .03 .01 (.07, .04) [.66] .08 (.02, .15) [.0109] .07 (.01, .13) [.03]
NOTE.—Glucose is measured in mmol/liter.
a The ﬁrst allele is rs1799884, and the second allele is rs3757840. The A allele of both SNPs is the relative glucose-raising allele.
the minimum success rate was 92.1% for rs2971671. The overall
genotype error rate in the initial part of the study was 0.6% (18
errors from 3,243 duplicate genotypes). Six of these duplicate
errors were for SNP rs2537185 ( error rate). Given6/141p 4.3%
this error rate and the departure from HWE, rs2537185 was ex-
cluded from further analysis. For the genotyping of rs1799884
and rs3757840, all cohorts were in HWE (all ), and the LDP 1 .10
statistics between the two SNPs were similar across all studies
( range 0.18–0.22; D′ range 0.98–1.00).2r
Population-Genetics Study
DNA samples.—We used a separate set of samples to test for
evolutionary neutrality in the GCK region.We surveyed sequence
variation in samples from three major ethnic groups: 16 Hausa
from Yaounde (Cameroon), 16 Han Chinese from Taiwan, and
16 individuals from central Italy; we used a European sample
separate from that used in the study SNP survey, because these
same population samples, together with the Hausa and Han Chi-
nese samples, were surveyed elsewhere at 50 unlinked noncoding
(therefore, putatively neutrally evolving) regions25,26 and at other
candidate diabetes genes.27 This is important because it helps dis-
tinguish between differences in patterns of sequence variation
due to demography alone and those due to selection and de-
mography. SNPs associated with fasting glucose or with possible
evidence of selection were genotyped in the Human Genome
Diversity Project (HGDP) panel of 1,052 individuals (of whom
927 are unrelated) from 52 populations. Sequence data were also
collected from one common chimpanzee, one gorilla, and one
orangutan, to determine the putative ancestral allele at each poly-
morphic site.
PCR ampliﬁcation and DNA sequencing.—Primers for PCR ampli-
ﬁcation and sequencing were designed using PRIMER.28 The sur-
vey included a segment of 17,355 bp centered on rs1799884 in
the GCK promoter and spanning the entire gene. PCR primers
were designed to amplify a 2,000–2,400-bp fragment, with at least
200 bp overlap between amplicons. Sequencing was performed
using internal sequencing primers with the ABI Big Dye Termi-
nator v. 3.1 Cycle Sequencing kit and with ABI 3700 or 3730
automated sequencers. The Phred-Phrap-Consed package was used
to assemble and analyze all sequences and score genotypes.29
Genotyping of HGDP.—On the basis of the fasting glucose as-
sociation results and the survey of population-genetics varia-
tion, three SNPs were genotyped in the HGDP panel: rs3757840,
rs1799884, and rs13239289. SNPs rs1799884 and rs13239289were
genotyped using the 5′ nuclease assay (TaqMan [Applied Biosys-
tems]). SNP rs3757840was genotyped by RFLP analysis with BglII.
Primer sequences and PCR conditions for both the 5′ nuclease
assays and the RFLP assay are available from the authors.
Data analysis.—Summary statistics of population variationwere
calculated using the online applications SLIDER andMAXDIP.25,30
The HKA test was performed using an online application. Hap-
lotypes were inferred, using PHASE2,31 in each population sample
separately. Coalescent simulations for the haplotype test were
performed with the assumption of values of estimated from4Nr
the data for each population sample.32 For all tests, gene con-
version was assumed to occur twice as often as crossover, and the
mean conversion tract length was 500 bp.
Results
LD Structure of the Glucokinase Region
The LD structure of the 116-kb region of GCK that is based
on 84 SNPs genotyped for 43 unrelated U.K. white subjects
is shown in ﬁgure 1. We compared the LD structure de-
termined by our resequencing of theGCK regionwith data
from HapMap 2 and from the Italian sample of the pop-
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Figure 4. A, Meta-analysis of the fasting glucose association
results of rs1799884 AA and AG versus GG for all studies. Studies
are ordered by ascending age of the cohort. Heterogeneity Pp
; combined . B, Meta-analysis of the fasting glu-9.94 Pp 1# 10
cose association results of rs3757840. The effect size per allele is
presented. Heterogeneity ; combined .7Pp .56 Pp 8# 10
ulation-genetics survey. Seventeen SNPs were in both the
HapMap 2 and our data set; ﬁgure 2 compares the data
sets. Twenty SNPs were identiﬁed by both the tSNP asso-
ciation study and the population-genetics survey of the
GCK region; ﬁgure 3 compares the data sets. Patterns of
LD were very similar across all three sets of samples.
tSNP Performance
Of the 23 genotyped tSNPs, 22 passed our stringent qual-
ity-control criteria. These 22 SNPs captured all 84 SNPs,
with a mean r2 of 0.837. Of the captured SNPs, 73% SNPs
were captured with an , 89% were captured with2r 1 0.8
an , and 98% were captured with an .2 2r 1 0.5 r 1 0.2
Initial tSNP Fasting Glucose Association Analysis
The results for the initial tSNP association analysis are
shown in table 1. Two SNPs, rs3757840 and rs1799884,
were nominally signiﬁcant.
Fasting Glucose Replication Studies
We next attempted to replicate the associations in an ad-
ditional 5,495 subjects from ﬁve further studies. The re-
sults for both SNPs in the individual cohorts are shown
in table 3 and ﬁgure 4. Overall, there was strong replica-
tion of the SNPs with fasting glucose in these cohorts
(overall combined P values: for rs1799884, ;9Pp 1# 10
for rs3757840, ). The result was very similar7Pp 8# 10
when samples with impaired fasting glucose (i.e., a cut-off
of 7 mmol/liter rather than 6 mmol/liter) were included.
Are There Two Independent Effects?
The SNPs rs1799884 and rs3757840 are 2,148 bp apart and
are in LD ( ; ). To determine whether these′ 2D p 1 r p 0.2
SNPs have independent effects on fasting glucose, we per-
formed haplotype analyses using the unphased program.23
The haplotype results are presented in table 4 and ﬁgure
5. Alleles from haplotypes formed by these two SNPs are
given as rs1799884, then rs3757840. The pairwise compar-
ison of the GA and the GC haplotypes (a test of rs3757840)
was only marginally signiﬁcant (ﬁg. 5A) (combined effect
mmol/liter; combined ). In contrast,sizep 0.02 Pp .03
the AA versus GA comparison (a test of rs1799884) was
highly signiﬁcant (ﬁg. 5B) (combined effect sizep 0.05
mmol/liter; ), and the GC versus AA com-5Pp 1# 10
parison (a test of both SNPs) was also signiﬁcant (ﬁg. 5C)
(combined effect mmol/liter; ).11sizep 0.06 Pp 1# 10
This strongly suggests that the rs1799884 SNP statistically
explains the association of the rs3757840 variantwith fast-
ing glucose. Regression analyses, which analyzed the effect
of one SNP on fasting glucose while adjusting for the other,
produced similar results (data not shown).
Birth-Weight Analysis for rs1799884
We next examined the effect of rs1799884 on birthweight,
using 6,366mothers and 7,232 offspring from the ALSPAC
study. Results are shown in table 5. We have replicated
our previous results, which shows that the presence of a
maternal A allele at rs1799884 is associated with an in-
crease of 27 g in offspring birth weight ( ). Correc-Pp .02
tion for fetal genotype did not affect the magnitude of
the association (26 g); we still found no evidence of a fetal
genotype effect, either before ( ) or after ( )Pp .72 Pp .56
correction for maternal genotype. When we combined this
result with our data published elsewhere,15 the maternal
genotype effect size was 32 g (95% CI 11–53 g) greater
birth weight for A allele carriers at rs1799884 ( ).Pp .002
Population-Genetics Analyses
The resequencing survey of 48 unrelated individuals from
three major ethnic groups, centered on the fasting glu-
cose–associated SNP rs1799884, yielded 112 polymor-
phisms: 105 biallelic SNPs and 7 insertion/deletions.
Summary statistics of sequence variation are presented
in table 6. Polymorphism levels are summarized in terms
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Table 5. ALSPAC Study Birth-Weight Association Results
for the rs1799884 Genotype
Genotype
Mean Birth Weight (SE) [No. of Subjects] for rs1799884
PaGG GA AA
Maternal 3,476 (6.7) [4,269] 3,501 (10.1) [1,905] 3,522 (31.8) [192] .02
Offspring 3,500 (6.3) [4,896] 3,507 (9.6) [2,090] 3,518 (30.9) [246] .72
NOTE.—Birth weight is measured in grams and is adjusted for gestational and sex.
a The P values are for a dominant model for the rs1799884 A allele.
Figure 5. Meta-analysis of the pairwise differences between haplotypes of rs1799884 and rs3757840 across fasting glucose. A, GA
versus GC. B, AA versus GA. C, AA versus GC. Heterogeneity , .41, and .65, respectively.Pp .40
of the number of polymorphic sites (S) and nucleotide
diversity per bp (p). Information about LD levels is sum-
marized by rH01, which is a composite likelihood estimator
of the population crossover–rate parameter ( , where N4Nr
is the effective population size and r is the crossover rate
between adjacent nucleotides).25,30 Tajima’sD summarizes
information about the spectrum of allele frequencies in
each sample33; a value near zero is expected under an equi-
librium-neutral model, whereas negative and positive val-
ues indicate, respectively, an excess of rare and interme-
diate frequency variants.
Contrary to the pattern observed in most studies of
human variation,26,34–39 GCK polymorphism levels in the
Hausa sample from sub-Saharan Africa are lower than
those observed in both non-African samples. We com-
pared these results with those of the 50 noncoding regions
surveyed in the same samples.26 Five of these regions were
more variable in the Italian than in the Hausa sample, but
none of them showed a difference as large as that observed
at GCK. When the Hausa and the Chinese samples were
compared, only one noncoding region showed a differ-
ence as large as that observed atGCK for the same samples.
Hence, polymorphism levels at GCK in the Hausa sample
appear to be unusually low relative to those observed in
the non-African samples, as might be expected if positive
natural selection drove a variant to ﬁxation in the Hausa
but not in the other samples. To test whether polymor-
phism levels in the Hausa are low relative to the expec-
tations of a standard neutralmodel, we used theHKA test40
to compare levels of polymorphism and sequence diver-
gence between human and chimpanzee atGCKwith those
observed at 50 noncoding regions surveyed in the same
samples. This test detected a nonsigniﬁcant deﬁcit of poly-
morphism levels in the Hausa ( ) and a nonsig-Pp .148
niﬁcant excess of polymorphism levels in the Italians and
Chinese ( and , respectively). Likewise,Pp .068 Pp .105
the allele-frequency spectrum is not unusual, compared
with the 50 noncoding regions in the same samples and
compared with the expectations of the standard neutral
model.
Visual inspection of the inferred haplotypes for each pop-
ulation sample revealed a haplotype class deﬁned by at
least seven SNPs (rs13306391, rs34976798, 65255 [nucleo-
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Table 6. Summary Statistics of Observed
Variation in the Resequencing Survey
Population Sa
pb
(%) Tajima’s Dc
rH01
d
(%)
Hausa 47 .060 .491 .0397
Italians 81 .122 .159 .0212
Chinese 75 .116 .268 .0270
a Number of variable sites.
b Nucleotide diversity per bp.
c Summary statistic of the allele frequency spectrum.25,30
d Composite likelihood estimator of the population re-
combination rate parameter ( ) based on a model of4Nr
gene conversion in which conversion events are twice as
common as crossover events and the conversion tract
length is geometrically distributed with mean 500 bp.
Table 7. Correlation between Allele Frequency and
Climate Variables in the HGDP Panel
Climate
Variablea
and Season
Findings for SNP
rs13239289 rs3757840 rs1799884
r P r P r P
Minimum:
Summer .277 .2176 .076 .6648 .081 .7916
Winter .542 .0209 .161 .4034 .103 .7580
Maximum:
Summer .223 .4184 .239 .1761 .146 .5966
Winter .549 .0126 .223 .3068 .029 .9445
Surface:
Summer .234 .2915 .200 .2159 .140 .5664
Winter .564 .0126 .211 .3182 .096 .7748
a Mean temperature.
tide position from start of AC006454, submitted to dbSNP],
rs13239289, rs34807880, rs34380942, and rs34780996) at
high frequency in the non-African samples (27 of 32 in-
ferred haplotypes) and ﬁxed in the Hausa sample. To de-
termine whether positive natural selection acted on this
haplotype class, we used the haplotype test,32 which de-
termines whether there is a deﬁcit of variation within a
haplotype class, given its frequency and relative to neu-
trality expectations. Brieﬂy, given the number of variable
sites in a population sample, coalescent simulations under
neutrality are performed to estimate the probability that
a haplotype subset of a given size has as few or fewer
polymorphic sites than in the observed haplotype distri-
bution. This test did not detect a signiﬁcant departure in
either the Italian or the Chinese data ( ).P 1 .2
We also used the results of a recent analysis of the phase
I data of the International HapMap Project to assess the
evidence of positive natural selection (Haplotter).41,42 The
analysis is based on a test statistic, called the “integrated
haplotype score” (IHS), which measures how unusual the
haplotypes around a given SNP are, relative to the ge-
nomewide HapMap data; the larger the absolute value of
IHS, the more unusual the haplotypes. TheGCK gene does
not show an unusual clustering of SNPs with large IHS
values ( in all HapMap population samples). WePp .99
also searched for three SNPs of interest: rs1799884 and
rs3757840, which are associated with variation in birth
weight and fasting glucose, and rs13239289,whichdeﬁnes
the high-frequency haplotype in the Italians and Chinese.
Because rs3757840 and rs13239289 are not in the Hap-
Map phase I data, we used surrogate SNPs rs7810158 and
rs3757838 ( and , respectively). None of the2 2r p 0.74 r p 1
SNPs is associated with an unusual haplotype structure on
a genomewide scale.
It was shown elsewhere that birth weight is inversely
correlated with heat stress, which raises the possibility that
genetic variation in birth weight may be shaped by se-
lective pressures related to climate variables.43 To assess
whether such spatially varying selective pressures acted
on variation in the GCK promoter, we genotyped three
SNPs in the HGDP panel. Two of the SNPs (rs1799884
and rs3757840) were chosen because they show a signif-
icant association with variation in birthweight and fasting
glucose. The third SNP (rs13239289) was chosen among
those that deﬁne the haplotype ﬁxed in the Hausa sample
and at near-ﬁxation frequency in the non-African samples.
We tested the null hypothesis of no correlation between
SNP allele frequency in each HGDP population and a set
of climate-related variables for the same populations by
using the Spearman rank correlation test. However, a cor-
relation with some of these variables might be expected
simply as a result of the history of human migrations and
may not necessarily reﬂect the action of spatially varying
selection. To determine whether the observed correlations
are unusual compared with empirical genomewide pat-
terns, we compared the rank correlation score for each
SNP with the distribution of rank correlation scores for a
set of microsatellite loci genotyped in the HGDP panel for
each climate variable, as described in the work of Thomp-
son et al.44; the proportion of microsatellites with more-
extreme rank correlation scores can be considered an em-
pirical P value for the correlation observed at the SNPs.
As shown in table 7, rs13239289 has a strong correla-
tion with temperature variables, which is unusual in com-
parison with the microsatellite distribution. However, this
SNP—as determined by genotyping rs34976798, which
deﬁnes the same haplotype and has an r2 of 1.0 with
rs13239289 in the 48 samples—is not associated with fast-
ing glucose ( ) in the tSNP analysis (table 1.)Pp .35
Discussion
Weperformed a tSNP association analysis of theglucokinase
gene to identify common genetic variants associated with
fasting glucose and birth weight. Using six studies, we con-
sistently replicated the association of a haplotype, deﬁned
by rs1799884—previously called “GCK(-30)”—with fast-
ing glucose and birth weight. Previous smaller studies of
GCK by ourselves and others15,45,46 that analyzed only
rs1799884 have found a similar increase in fasting glucose
associated with the A allele. Our results provide evidence
that this variant alters fasting glucose at genomewide lev-
els of signiﬁcance. Not all individual studies provided sig-
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niﬁcant evidence of association, and some provided stron-
ger evidence for rs3757840, a SNP partially correlatedwith
rs1799884, with an r2 of 0.22. Our results highlight the
importance of using multiple replication studies to estab-
lish the true effect of common variants on common phe-
notypes. Our results also indicate that association signals
may be detected with SNPs with r2 values as low as 0.22.
Our tSNP analysis found no evidence that GCK vari-
ation, other than the variation in the haplotype that
includes rs1799884, affects GCK activity. The tSNP with
the highest r2 with rs1799884—rs3757840—was associ-
ated with fasting glucose, but the association is explained
statistically by LD with rs1799884 ( ). We also2r p 0.22
note that the tSNP rs2971671, with the second highest r2
with rs1799884 ( ), was close to reaching nominal2r p 0.19
signiﬁcance in our initial study ( ). The identiﬁ-Pp .054
cation of the signal of rs1799884 with use of a SNP with
a low r2 highlights the potential of using a tSNP approach
for association studies in identiﬁcation of common vari-
ants for complex traits. This is important, since the utility
in identiﬁcation of common disease variants of the Hap-
Map project and whole-genome association studies has
been questioned.47
We have replicated our previous ﬁnding that the mater-
nal rs1799884 genotype inﬂuences offspring birth weight.
The association of maternal rs1799884 with offspring
birth weight (27 g) is, as predicted, from the correlation
between maternal glucose concentration and offspring
birth weight—on the basis of regression of maternal preg-
nant glucose and birth weight in the EFS mothers, a 0.08
mmol/liter increase in fasting glucose would be expected
to increase birth weight by 21 g. We found no evidence
that fetal genotype is associated with offspring birthweight
(A allele effect g; ).sizep 4 Pp .72
The population-genetics analyses of GCK was centered
on the rs1799884 SNP associated with fasting glucose and
revealed a few interesting patterns. An extended haplo-
type deﬁned by the derived allele at 17 SNPs occurs at
high frequency (84%) in the two non-African samples and
is ﬁxed in the Hausa sample. Accordingly, the Hausa sam-
ple exhibits lower polymorphism levels compared with
the non-African samples. This could be consistent with a
complete selective sweep in the Hausa sample and a nearly
complete sweep in the non-African samples. However, a
statistical test aimed at determining whether the deﬁcit
of polymorphism in the Hausa is inconsistent with evo-
lutionary neutrality failed to reject the null hypothesis
( ). Likewise, the haplotype test did not yield sig-Pp .148
niﬁcant results in the non-African samples. Although
these results may be due to limited power of the tests, we
conclude that there is no evidence in the resequencing
data to indicate recent positive natural selection. Inter-
estingly, however, one of the SNPs deﬁning the haplotype
ﬁxed in the Hausa and at high frequency in the non-
African samples shows a strong correlation with climate
variables. Given the reported correlation between birth
weight and indices of heat stress,45 it is tantalizing to spec-
ulate that GCK variation linked to this haplotype may
have been shaped by spatially varying selective pressures
related to climate.
We also asked whether the variants contributing to fast-
ing glucose and birth-weight variation in our association
studies were associated with a selective advantage. How-
ever, neither our resequencing data nor an analysis of the
HapMap phase I data suggests that this is the case. Given
the small phenotypic effect of rs1799884 on birth weight
(i.e., ∼32 g), it is perhaps not surprising that no ﬁtness
effect appears to be associated with this variant.
Other important conclusions can be drawn from our
study. The effect of rs1799884 on fasting glucose is con-
stant in groups of subjects whose median age varied from
8 years to 71.5 years (heterogeneity ) when a cutoffPp .94
of 6 mmol/liter is taken (i.e., normal glucose-tolerant sub-
jects only).
In conclusion, we have comprehensively assessed the
role of the glucokinase gene in determining fastingglucose
level and birth weight. Birth weight is a trait strongly in-
ﬂuenced by evolutionary pressure, but a comprehensive
analysis of GCK did not reveal any consistent signals of
recent positive selection. We have reproducibly, and at ge-
nomewide levels of signiﬁcance, identiﬁed a common hap-
lotype of the glucokinase gene that affects fasting glucose
and birth weight.
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